High Tower Advisors, LLC Hcw Biologics Inc. Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 180,810 shares of HCWB stock, worth $70,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180,810
Previous 180,810
-0.0%
Holding current value
$70,515
Previous $97,000
20.62%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.13MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.02MShares$789,2280.01% of portfolio
-
Avantax Planning Partners, Inc.280KShares$109,0200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$70,9630.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$51,4760.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$29,2950.03% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...